Applications including "USP draft"

LB990 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB989 - Analysis of Xylazine -

LC InertSearch InertSustain C18
LB988 - Analysis of Xylazine -

LC InertSearch InertSustainSwift C8
LB987 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB974 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB965 - Analysis of Nicardipine Hydrochloride -

LC InertSearch InertSustain C8
LB961 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB960 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
GA382 - Analysis of Menthol -

GC InertSearch InertCap Pure-WAX
LB958 - Analysis of Methyltestosterone and Progesterone -

LC InertSearch Insertsil WP300 C18
LB956 - Analysis of Sumatriptan succinate and Naproxen Sodium -

LC InertSearch Insertsil Ph-3
LB947 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB946 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB945 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB931 - Analysis of Acyclovir -

LC InertSearch Inertsil ODS-3
LB925 - Analysis of Acyclovir -

LC InertSearch InertSustain Cyano
LB924 - Analysis of Acyclovir -

LC InertSearch InertSustain Cyano
LB919 - Analysis of Pitavastatin Calcium -

LC InertSearch InertCore Plus C18
LB914 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB913 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB900 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustain C8
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
GA352 - Analysis of Dipropylene Glycol -

GC InertSearch InertCap WAX-HT
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB895 - Analysis of Venlafaxine hydrochloride -

LC InertSearch InertSustainSwift C8
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB889 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB888 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB887 - Analysis of Propyl gallate -

LC InertSearch Inertsil ODS-4
LB885 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB884 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LC InertSearch InertSustain AQ-C18 HP
LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LC InertSearch InertSustainSwift C18
LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LC InertSearch Inertsil ODS-3
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LC InertSearch InertSustain C18
LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph
LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph-3
LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenylhexyl
LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenyl

Applications including "USP draft"

LB990 - Analysis of Xylazine -

LB989 - Analysis of Xylazine -

LB988 - Analysis of Xylazine -

LB987 - Analysis of Xylazine -

LB974 - Analysis of Dapagliflozin propandiol -

LB965 - Analysis of Nicardipine Hydrochloride -

LB961 - Analysis of Lidocaine -

LB960 - Analysis of Lidocaine -

GA382 - Analysis of Menthol -

LB958 - Analysis of Methyltestosterone and Progesterone -

LB956 - Analysis of Sumatriptan succinate and Naproxen Sodium -

LB947 - Analysis of Glacial Acetic Acid -

LB946 - Analysis of Glacial Acetic Acid -

LB945 - Analysis of Glacial Acetic Acid -

LB931 - Analysis of Acyclovir -

LB925 - Analysis of Acyclovir -

LB924 - Analysis of Acyclovir -

LB919 - Analysis of Pitavastatin Calcium -

LB914 - Analysis of Saxagliptin -

LB913 - Analysis of Saxagliptin -

LB912 - Analysis of Metformin Hydrochloride -

LB911 - Analysis of Metformin Hydrochloride -

LB902 - Analysis of Saxagliptin -

LB901 - Analysis of Saxagliptin -

LB900 - Analysis of Fesoterodine Fumarate -

LB899 - Analysis of Fesoterodine Fumarate -

GA352 - Analysis of Dipropylene Glycol -

LB896 - Analysis of Triptorelin Pamoate -

LB895 - Analysis of Venlafaxine hydrochloride -

LB891 - Analysis of Saxagliptin -

LB890 - Analysis of Saxagliptin -

LB889 - Analysis of Propyl gallate -

LB888 - Analysis of Propyl gallate -

LB887 - Analysis of Propyl gallate -

LB885 - Analysis of Voriconazole -

LB884 - Analysis of Voriconazole -

LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

Application Search